National Healthcare (NHC) Q3 FY2026 earnings: revenue $408 million, up 6.6% on the year
National Healthcare Corp. (NHC) reported revenue of $408 million for Q3 FY2026, the quarter ended 30 September 2026, up 6.6% on the same quarter a year earlier. Net income was $14 million, down 65.2% on the year, and diluted earnings per share $0.85. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2026.
Revenue
$408 million
+6.6% on the year · -0.0% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
10.0%
7.9% a year earlier
Q4 FY2024Q3 FY2026
Net income
$14 million
-65.2% on the year · -66.2% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$0.85
-66.0% on the year · -66.5% on the quarter
Q4 FY2024Q3 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Net operating revenues rose 6.6%: Net operating revenues were $407,971,000 against $382,661,000 a year earlier. Net patient revenues were $397,446,000 and other revenues $10,525,000, down from $11,672,000.
Adjusted net income rose 13.8%: Adjusted net income was $28,154,000 against $24,744,000, a 13.8% increase. Adjusted diluted EPS was $1.76 against $1.58 a year earlier.
GAAP net income was lower: GAAP net income attributable to NHC was $13,637,000 against $39,239,000. GAAP diluted EPS was $0.85 against $2.50 a year earlier.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
99.2
43.3
66.2
+129.2%
+49.8%
Capital expenditure
n/a
12.5
9.7
Free cash flow
n/a
30.7
56.5
Free cash flow margin
n/a
7.5%
14.8%
Cash from investing
-557
-87.7
2.0
Cash from financing
492
-9.7
-47.0
Depreciation and amortisation
14.6
11.2
11.2
+30.5%
+30.6%
Share-based compensation
2.0
2.0
1.2
+1.7%
+63.0%
Buybacks
1.1
7.2
3.2
-84.7%
-65.1%
Dividends paid
10.5
10.0
9.9
+5.0%
+5.8%
Dividend per share
$0.67
$0.67
$0.64
0.0%
+4.7%
Diluted shares, weighted
16m
16m
16m
+0.6%
+1.9%
Shares outstanding at period end
16m
16m
16m
+0.0%
+1.0%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
1,125
1,122
1,053
+0.2%
+6.8%
Non-controlling interest
6.3
5.8
5.2
+9.5%
+20.0%
Debt
502
0.0
73.1
+586.6%
Operating lease liabilities
13.7
13.1
21.7
+4.1%
-37.2%
Other liabilities
421
396
419
+6.4%
+0.5%
Total liabilities and equity
2,068
1,537
1,572
+34.6%
+31.6%
Fixed assets
1,290
727
675
+77.5%
+91.1%
Goodwill
170
170
170
0.0%
0.0%
Intangible assets
20.4
20.4
19.9
0.0%
+2.5%
Securities held for sale or to maturity
114
119
123
-4.3%
-7.1%
Cash and equivalents
66.8
39.2
131
+70.4%
-48.9%
Receivables
130
138
132
-5.8%
-2.0%
Inventory
8.7
8.5
7.8
+1.4%
+10.4%
Other assets
268
315
313
-14.8%
-14.3%
Total assets
2,068
1,537
1,572
+34.6%
+31.6%
Questions
What was National Healthcare's revenue in Q3 FY2026?
National Healthcare (NHC) reported revenue of $408 million for Q3 FY2026, the quarter ended 30 September 2026, up 6.6% on the same quarter a year earlier.
How much did National Healthcare earn in Q3 FY2026?
Net income for Q3 FY2026 was $14 million, down 65.2% on the year, and diluted earnings per share $0.85.
When did National Healthcare report Q3 FY2026 results?
National Healthcare filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 5 November 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 September 2026, filed 5 November 2026: the filing.